const L125 = [
  {
    "id": 1,
    "category": "Tetracyclines: Mechanism of Action",
    "questionText": "A 20-year-old college student presents with a persistent, dry cough and is diagnosed with atypical pneumonia caused by *Mycoplasma pneumoniae*. The patient is treated with doxycycline. What is the mechanism of action of this antibiotic?",
    "options": [
      {"text": "It binds to the 50S subunit and blocks the polypeptide exit tunnel.", "explanation": "This is incorrect. This is the mechanism of action for macrolides."},
      {"text": "It binds reversibly to the 30S subunit, blocking the A site.", "explanation": "This is correct. Tetracyclines bind reversibly to the 16S rRNA of the 30S subunit and block the acceptor (A) site, preventing aminoacyl-tRNA from binding."},
      {"text": "It binds to the 50S subunit, preventing the formation of the 70S initiation complex.", "explanation": "This is incorrect. This is the mechanism of action for linezolid."},
      {"text": "It binds to the 30S subunit and causes misreading of the mRNA.", "explanation": "This is incorrect. This is a mechanism of aminoglycosides."},
      {"text": "It inhibits bacterial DNA gyrase.", "explanation": "This is incorrect. This is the mechanism of fluoroquinolones."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0023.jpg"
  },
  {
    "id": 2,
    "category": "Tetracyclines: Pharmacokinetics (Interactions)",
    "questionText": "A 19-year-old female is prescribed oral tetracycline for acne. She is counseled to avoid taking it with her multivitamins (containing iron and calcium) and antacids. Why is this counseling critical for therapeutic success?",
    "options": [
      {"text": "The antibiotics will inactivate the vitamins, leading to a deficiency.", "explanation": "This is incorrect. The interaction affects the *antibiotic's* absorption, not the vitamins' activity."},
      {"text": "Di- and trivalent cations chelate the tetracycline, preventing its absorption.", "explanation": "This is correct. Divalent ($Ca^{2+}$) and trivalent ($Fe^{3+}$) cations in food or supplements form non-absorbable chelates with tetracyclines in the GI tract, which significantly decreases drug absorption and bioavailability."},
      {"text": "The combination significantly increases the risk of Fanconi syndrome.", "explanation": "This is incorrect. Fanconi syndrome is associated with outdated tetracycline, not this interaction."},
      {"text": "Antacids will neutralize the drug, rendering it chemically inert.", "explanation": "This is incorrect. The issue is chelation, not acid-base neutralization."},
      {"text": "This combination is known to cause severe, irreversible ototoxicity.", "explanation": "This is incorrect. This interaction does not cause ototoxicity."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0021.jpg"
  },
  {
    "id": 3,
    "category": "Tetracyclines: Adverse Effects (Pediatrics)",
    "questionText": "A 6-year-old boy in North Carolina presents with high fever, headache, and a petechial rash starting on his wrists and ankles. Rocky Mountain spotted fever (RMSF) is suspected. Doxycycline is the drug of choice, despite the patient's age. Why is doxycycline now considered acceptable by the AAP for this indication?",
    "options": [
      {"text": "RMSF is intrinsically resistant to all other antibiotics.", "explanation": "This is incorrect. Chloramphenicol is an alternative, though more toxic."},
      {"text": "Doxycycline is the only tetracycline that does not cross the placenta.", "explanation": "This is incorrect. Tetracyclines as a class cross the placenta."},
      {"text": "Doxycycline has a low affinity for calcium and is not shown to cause tooth staining in short courses (≤21 days).", "explanation": "This is correct. The AAP supports doxycycline use in children because it binds calcium less avidly than older tetracyclines, and studies show no staining with short courses, making the benefit of treating deadly RMSF far outweigh the low risk."},
      {"text": "The child's permanent teeth have already fully formed and erupted.", "explanation": "This is incorrect. At age 6, many permanent teeth are still developing and calcifying."},
      {"text": "Doxycycline is metabolized by the liver and is not cleared renally.", "explanation": "This is incorrect. While true that doxycycline is excreted in the feces, this is not the reason it is preferred in children over other tetracyclines."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0022.jpg"
  },
  {
    "id": 4,
    "category": "Tetracyclines: Resistance",
    "questionText": "A *Staphylococcus aureus* isolate is found to be resistant to tetracycline, but it remains susceptible to doxycycline and minocycline. This specific resistance pattern is conferred by which of the following mechanisms?",
    "options": [
      {"text": "The Tet(M) ribosomal protection protein.", "explanation": "This is incorrect. Tet(M) confers resistance to tetracycline, doxycycline, and minocycline."},
      {"text": "The Tet(K) efflux pump.", "explanation": "This is correct. The Tet(K) efflux pump, expressed by staphylococci, confers resistance to tetracycline but *not* to doxycycline or minocycline."},
      {"text": "The Tet(AE) efflux pump.", "explanation": "This is incorrect. Tet(AE) is found in gram-negative bacteria and confers resistance to tetracycline, doxycycline, and minocycline."},
      {"text": "Chromosomally encoded MDR efflux pumps.", "explanation": "This is incorrect. This is the mechanism of intrinsic resistance in *Pseudomonas* and *Proteus*."},
      {"text": "Enzymatic inactivation by acetyltransferase.", "explanation": "This is incorrect. This is a minor resistance mechanism for tetracyclines but the primary one for chloramphenicol."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0024.jpg"
  },
  {
    "id": 5,
    "category": "Tetracyclines: Resistance",
    "questionText": "An isolate of *Streptococcus pneumoniae* is found to be resistant to doxycycline. The mechanism is determined to be a ribosomal protection protein that interferes with drug binding. This mechanism is mediated by which gene/protein?",
    "options": [
      {"text": "Tet(K) protein", "explanation": "This is incorrect. Tet(K) is an efflux pump found in staphylococci."},
      {"text": "Tet(AE) protein", "explanation": "This is incorrect. Tet(AE) is an efflux pump found in gram-negative bacteria."},
      {"text": "Tet(M) protein", "explanation": "This is correct. The Tet(M) ribosomal protection protein, expressed by gram-positives like streptococci, confers resistance to tetracycline, doxycycline, and minocycline by interfering with drug binding."},
      {"text": "An *erm* gene methylase", "explanation": "This is incorrect. This confers $MLS_B$ resistance (macrolides, clindamycin)."},
      {"text": "A KPC carbapenemase", "explanation": "This is incorrect. This is a beta-lactamase."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0024.jpg"
  },
  {
    "id": 6,
    "category": "Tetracyclines: Clinical Use (Zoonoses)",
    "questionText": "A 30-year-old hiker from Connecticut presents in July with an expanding, annular, erythematous rash (erythema migrans) and flu-like symptoms. This presentation is classic for Lyme disease, caused by the spirochete *Borrelia* spp. What is the first-line oral treatment?",
    "options": [
      {"text": "Gentamicin", "explanation": "This is incorrect. Aminoglycosides are not first-line for Lyme disease."},
      {"text": "Linezolid", "explanation": "This is incorrect. Linezolid is not used for Lyme disease."},
      {"text": "Doxycycline", "explanation": "This is correct. Doxycycline is the drug of choice for the treatment of zoonotic infections like Lyme disease."},
      {"text": "Clindamycin", "explanation": "This is incorrect. Clindamycin is not first-line for Lyme disease."},
      {"text": "Azithromycin", "explanation": "This is incorrect. While azithromycin has activity against *Borrelia*, doxycycline is the preferred first-line agent."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0025.jpg"
  },
  {
    "id": 7,
    "category": "Tetracyclines: Clinical Use (Atypicals)",
    "questionText": "A 24-year-old patient presents with symptoms of urethritis. A nucleic acid amplification test is positive for *Chlamydia trachomatis*. What is a recommended first-line agent for this infection?",
    "options": [
      {"text": "Penicillin G", "explanation": "This is incorrect. Beta-lactams are not effective against atypical bacteria like *Chlamydia*."},
      {"text": "Doxycycline", "explanation": "This is correct. Doxycycline is a first-line agent for STDs caused by the atypical bacterium *Chlamydia trachomatis*."},
      {"text": "Vancomycin", "explanation": "This is incorrect. Vancomycin is not effective against atypical bacteria."},
      {"text": "Streptomycin", "explanation": "This is incorrect. Aminoglycosides are not effective against atypical bacteria."},
      {"text": "Chloramphenicol", "explanation": "This is incorrect. Chloramphenicol is not effective against *Chlamydia*."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0026.jpg"
  },
  {
    "id": 8,
    "category": "Tetracyclines: Adverse Effects",
    "questionText": "A 23-year-old female taking doxycycline for acne complains of developing a severe, painful sunburn after spending only 30 minutes at the beach. What is this adverse reaction called?",
    "options": [
      {"text": "Photosensitivity", "explanation": "This is correct. Tetracyclines can cause photosensitivity, a reaction to sun-exposed skin that can range from mild to a severe, third-degree burn."},
      {"text": "Hypersensitivity", "explanation": "This is incorrect. While technically a hypersensitivity, 'photosensitivity' is the specific term for this light-induced reaction."},
      {"text": "Fanconi syndrome", "explanation": "This is incorrect. This is a rare renal toxicity from outdated tetracycline."},
      {"text": "Vestibular toxicity", "explanation": "This is incorrect. This is an ototoxicity associated with minocycline, presenting as dizziness."},
      {"text": "Blue-gray skin discoloration", "explanation": "This is incorrect. This is a different skin-related adverse effect of long-term minocycline use."}
    ],
    "correctAnswerIndex": 0,
    "slideImagePath": "images/L125_page-0028.jpg"
  },
  {
    "id": 9,
    "category": "Tetracyclines: Adverse Effects/Use",
    "questionText": "A 60-year-old male with small cell lung cancer has persistent hyponatremia due to Syndrome of Inappropriate Antidiuretic Hormone (SIADH). Which tetracycline derivative is known for its \"claim to fame\" of causing nephrogenic diabetes insipidus, making it a historical treatment for this condition?",
    "options": [
      {"text": "Doxycycline", "explanation": "This is incorrect. Doxycycline does not typically cause this effect."},
      {"text": "Minocycline", "explanation": "This is incorrect. Minocycline is associated with vestibular toxicity, not NDI."},
      {"text": "Tigecycline", "explanation": "This is incorrect. Tigecycline is not used for this purpose."},
      {"text": "Demeclocycline", "explanation": "This is correct. Demeclocycline is not used as an antibiotic but was historically used for SIADH because it uniquely causes renal insensitivity to ADH (nephrogenic diabetes insipidus)."},
      {"text": "Sarecycline", "explanation": "This is incorrect. This is a narrow-spectrum agent for acne."}
    ],
    "correctAnswerIndex": 3,
    "slideImagePath": "images/L125_page-0027.jpg"
  },
  {
    "id": 10,
    "category": "Tetracyclines: Adverse Effects",
    "questionText": "A 25-year-old patient takes a bottle of expired tetracycline. They present to the emergency department with polyuria, glycosuria, aminoaciduria, and a non-anion gap metabolic acidosis. This constellation of proximal renal tubular dysfunction is known as:",
    "options": [
      {"text": "Gray baby syndrome", "explanation": "This is incorrect. This is a toxicity of chloramphenicol in neonates."},
      {"text": "Nephrogenic diabetes insipidus", "explanation": "This is incorrect. This is a specific toxicity of demeclocycline involving water reabsorption, not a generalized tubular dysfunction."},
      {"text": "Fanconi syndrome", "explanation": "This is correct. Outdated, degraded tetracycline is highly toxic to the kidneys and can cause Fanconi syndrome, a generalized proximal tubular dysfunction."},
      {"text": "Acute tubular necrosis (ATN)", "explanation": "This is incorrect. While ATN can occur, 'Fanconi syndrome' is the specific term for this collection of proximal tubule defects."},
      {"text": "Serotonin syndrome", "explanation": "This is incorrect. This is an interaction with linezolid."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0028.jpg"
  },
  {
    "id": 11,
    "category": "Tetracyclines: Adverse Effects (Tigecycline)",
    "questionText": "A 70-year-old patient in the ICU has a ventilator-associated pneumonia (VAP). The physician considers using tigecycline due to its broad spectrum. Why is this drug explicitly contraindicated for VAP?",
    "options": [
      {"text": "It is inactivated by pulmonary surfactant.", "explanation": "This is incorrect. This describes daptomycin."},
      {"text": "It is only available in an oral formulation.", "explanation": "This is incorrect. Tigecycline is IV only."},
      {"text": "It causes Fanconi syndrome in elderly patients.", "explanation": "This is incorrect. This is a toxicity of outdated tetracycline."},
      {"text": "It is associated with lower cure rates and increased all-cause mortality in this setting.", "explanation": "This is correct. Tigecycline has a contraindication for HAP/VAP because clinical trials demonstrated lower efficacy and an increase in all-cause mortality compared to other antibiotics."},
      {"text": "It does not have activity against *Pseudomonas aeruginosa*.", "explanation": "This is incorrect. While true that *P. aeruginosa* is intrinsically resistant, this is not the reason for the black box warning; the reason is increased mortality."}
    ],
    "correctAnswerIndex": 3,
    "slideImagePath": "images/L125_page-0027.jpg"
  },
  {
    "id": 12,
    "category": "Macrolides: Mechanism of Action",
    "questionText": "A patient with community-acquired pneumonia is treated with azithromycin. What is the mechanism of action for this macrolide?",
    "options": [
      {"text": "Binds to the 30S subunit, blocking the A-site.", "explanation": "This is incorrect. This is the mechanism of tetracyclines."},
      {"text": "Binds to the 50S subunit and blocks the polypeptide exit tunnel.", "explanation": "This is correct. Macrolides bind to the 23S rRNA of the 50S subunit and block the polypeptide exit tunnel, thereby inhibiting the translocation step of elongation."},
      {"text": "Binds to the 50S subunit, preventing the 70S initiation complex from forming.", "explanation": "This is incorrect. This is the mechanism of linezolid."},
      {"text": "Binds to the 30S subunit, causing misreading of mRNA.", "explanation": "This is incorrect. This is the mechanism of aminoglycosides."},
      {"text": "Binds to DNA gyrase.", "explanation": "This is incorrect. This is the mechanism of fluoroquinolones."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0032.jpg"
  },
  {
    "id": 13,
    "category": "Macrolides: Pharmacokinetics (Interactions)",
    "questionText": "A 65-year-old male on long-term simvastatin for hyperlipidemia is prescribed clarithromycin for an *H. pylori* infection. He develops severe muscle pain and rhabdomyolysis. This toxicity is due to clarithromycin's potent inhibition of which enzyme?",
    "options": [
      {"text": "CYP2C9", "explanation": "This is incorrect. CYP2C9 is inhibited by chloramphenicol and metabolizes warfarin."},
      {"text": "CYP3A4", "explanation": "This is correct. Erythromycin and clarithromycin are strong inhibitors of CYP3A4, which metabolizes many drugs, including statins. This interaction leads to toxic levels of the statin."},
      {"text": "UDP-glucuronyltransferase (UGT)", "explanation": "This is incorrect. This enzyme metabolizes chloramphenicol and is immature in neonates."},
      {"text": "Monoamine Oxidase (MAO)", "explanation": "This is incorrect. This is inhibited by linezolid."},
      {"text": "Aldehyde Dehydrogenase", "explanation": "This is incorrect. This is inhibited by cefotetan."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0036.jpg"
  },
  {
    "id": 14,
    "category": "Macrolides: Pharmacokinetics",
    "questionText": "A 30-year-old female is given a 5-day \"Z-Pak\" (azithromycin) for a respiratory infection. This short course is effective for a 10-day infection. What unique pharmacokinetic property of azithromycin allows for this?",
    "options": [
      {"text": "It is a potent inducer of CYP3A4.", "explanation": "This is incorrect. It is not a CYP3A4 inhibitor, and induction would decrease its half-life."},
      {"text": "It is eliminated 100% unchanged in the urine.", "explanation": "This is incorrect. It is excreted in the bile."},
      {"text": "It is sequestered in tissues and has a very long half-life (~70 hours).", "explanation": "This is correct. Azithromycin is sequestered in tissues and has an extremely long half-life (around 70 hours), allowing for once-daily dosing and a prolonged antimicrobial effect even after the 5-day course is finished."},
      {"text": "It is converted to a long-acting metabolite in the lungs.", "explanation": "This is incorrect. Its long half-life is due to tissue sequestration, not a metabolite."},
      {"text": "It has 100% oral bioavailability.", "explanation": "This is incorrect. Its bioavailability is ~50% (for clarithromycin) or ~40% (for azithromycin). Linezolid has 100% bioavailability."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0031.jpg"
  },
  {
    "id": 15,
    "category": "Macrolides: Resistance ($MLS_B$)",
    "questionText": "An isolate of *S. pneumoniae* is found to be resistant to erythromycin, clindamycin, and streptogramin B. This $MLS_B$ resistance phenotype is conferred by what molecular mechanism?",
    "options": [
      {"text": "An efflux pump encoded by the *tet(K)* gene.", "explanation": "This is incorrect. This is a tetracycline resistance mechanism in *Staph*."},
      {"text": "An efflux pump encoded by the *mefA* gene.", "explanation": "This is incorrect. This efflux pump confers resistance to macrolides, but not to clindamycin or streptogramin B."},
      {"text": "Production of a methylase encoded by an *erm* gene.", "explanation": "This is correct. The $MLS_B$ phenotype is caused by an *erm* gene, which produces a methylase that modifies the 23S rRNA binding site, conferring cross-resistance to macrolides, lincosamides, and streptogramin B."},
      {"text": "Production of an acetyltransferase.", "explanation": "This is incorrect. This is the resistance mechanism for chloramphenicol."},
      {"text": "Mutation of the 16S rRNA binding site.", "explanation": "This is incorrect. This is the 30S subunit, the target of tetracyclines and aminoglycosides."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0033.jpg"
  },
  {
    "id": 16,
    "category": "Macrolides: Clinical Use",
    "questionText": "A 55-year-old man, a heavy smoker, presents with community-acquired pneumonia. The physician suspects an 'atypical' pathogen like *Legionella pneumophila*. Why are macrolides (like azithromycin) a good choice for this specific intracellular pathogen?",
    "options": [
      {"text": "They are bactericidal against all gram-negative rods.", "explanation": "This is incorrect. Macrolides are bacteriostatic and have a limited gram-negative spectrum."},
      {"text": "They are the only antibiotics that penetrate lung tissue.", "explanation": "This is incorrect. Many antibiotics penetrate the lungs."},
      {"text": "They concentrate in neutrophils and macrophages, where *Legionella* replicates.", "explanation": "This is correct. Macrolides accumulate in pulmonary tissue and phagocytic cells, which is where intracellular pathogens like *Legionella* and *Chlamydia* live and replicate."},
      {"text": "They are not metabolized by CYP3A4.", "explanation": "This is incorrect. Erythromycin and clarithromycin *are* metabolized by CYP3A4."},
      {"text": "They are effective against all resistant organisms.", "explanation": "This is incorrect. Macrolide resistance is widespread."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0031.jpg"
  },
  {
    "id": 17,
    "category": "Macrolides: Adverse Effects",
    "questionText": "A patient with gastroparesis is given erythromycin. He develops nausea and abdominal cramps. This GI side effect is due to erythromycin's agonist activity at which receptor?",
    "options": [
      {"text": "Dopamine (D2) receptor", "explanation": "This is incorrect. D2 *antagonists* (like metoclopramide) are used for gastroparesis."},
      {"text": "Serotonin (5-HT3) receptor", "explanation": "This is incorrect. 5-HT3 *antagonists* (like ondansetron) are anti-emetics."},
      {"text": "Motilin receptor", "explanation": "This is correct. Erythromycin is a prokinetic agent because it stimulates motilin receptors in the upper GI tract, increasing motility. This same action causes the common side effects of cramps and nausea."},
      {"text": "Muscarinic (M3) receptor", "explanation": "This is incorrect. M3 agonists (like bethanechol) could increase motility, but this is not erythromycin's mechanism."},
      {"text": "Histamine (H2) receptor", "explanation": "This is incorrect. H2 antagonists (like famotidine) decrease gastric acid."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0035.jpg"
  },
  {
    "id": 18,
    "category": "Macrolides: Adverse Effects",
    "questionText": "A 70-year-old patient on amiodarone for atrial fibrillation is given azithromycin for CAP. He develops syncope. An EKG would most likely show an increased risk for which arrhythmia?",
    "options": [
      {"text": "Atrial fibrillation", "explanation": "This is incorrect. The patient is already being treated for this."},
      {"text": "Torsades de pointes", "explanation": "This is correct. All macrolides can increase the QT interval by affecting cardiac potassium channels. This risk is additive with other QT-prolonging drugs (like amiodarone), leading to torsades de pointes."},
      {"text": "Supraventricular tachycardia (SVT)", "explanation": "This is incorrect. This is not the characteristic arrhythmia."},
      {"text": "Complete heart block", "explanation": "This is incorrect. This is not the characteristic arrhythmia."},
      {"text": "Ventricular fibrillation (V-fib)", "explanation": "This is incorrect. While Torsades *can* degenerate into V-fib, Torsades de pointes is the specific drug-induced arrhythmia."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0035.jpg"
  },
  {
    "id": 19,
    "category": "Clindamycin: Mechanism of Action",
    "questionText": "A patient is treated with clindamycin for a skin abscess. What is the mechanism of action for this lincosamide antibiotic?",
    "options": [
      {"text": "It binds to the 30S subunit, blocking the A-site.", "explanation": "This is incorrect. This is the mechanism of tetracyclines."},
      {"text": "It binds to the 23S rRNA of the 50S subunit near the peptidyl transferase center.", "explanation": "This is correct. Clindamycin binds to the 50S subunit at a site overlapping with macrolides, interfering with peptide bond formation and translocation."},
      {"text": "It binds to the 50S subunit, preventing the 70S initiation complex from forming.", "explanation": "This is incorrect. This is the mechanism of linezolid."},
      {"text": "It binds to the 30S subunit and causes misreading of the mRNA.", "explanation": "This is incorrect. This is the mechanism of aminoglycosides."},
      {"text": "It binds to and depolarizes the cell membrane.", "explanation": "This is incorrect. This is the mechanism of daptomycin."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0037.jpg"
  },
  {
    "id": 20,
    "category": "Clindamycin: Spectrum of Activity",
    "questionText": "Clindamycin is a narrow-spectrum antibiotic. Its spectrum of activity is primarily limited to which groups of organisms?",
    "options": [
      {"text": "Aerobic gram-negative bacilli only", "explanation": "This is incorrect. It is intrinsically resistant against aerobic gram-negative bacilli."},
      {"text": "Gram-positive aerobes (including caMRSA) and anaerobes", "explanation": "This is correct. Clindamycin's narrow spectrum covers gram-positive aerobes (like *Strep*, *Staph*, and community-acquired MRSA) and gram-positive and gram-negative anaerobes."},
      {"text": "Atypical bacteria only (*Mycoplasma*, *Chlamydia*)", "explanation": "This is incorrect. This is a key part of the macrolide and tetracycline spectrums, not clindamycin."},
      {"text": "Gram-positive aerobes only", "explanation": "This is incorrect. A key feature of clindamycin is its excellent *anaerobic* coverage."},
      {"text": "All gram-positive and all gram-negative bacteria", "explanation": "This is incorrect. It is a *narrow-spectrum* drug and does not cover aerobic gram-negatives."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0038.jpg"
  },
  {
    "id": 21,
    "category": "Clindamycin: Adverse Effects",
    "questionText": "A 45-year-old male is treated with clindamycin for a dental infection. Two weeks later, he develops profuse watery diarrhea, fever, and abdominal pain. This is most likely due to an overgrowth of which organism?",
    "options": [
      {"text": "*Staphylococcus aureus* (MRSA)", "explanation": "This is incorrect. Clindamycin is often used to *treat* MRSA."},
      {"text": "*Enterococcus faecium* (VRE)", "explanation": "This is incorrect. *Enterococcus* is intrinsically resistant but doesn't typically cause antibiotic-associated diarrhea this way."},
      {"text": "*Clostridioides difficile*", "explanation": "This is correct. Clindamycin has a high association with causing *C. difficile*-associated diarrhea (CDAD) and pseudomembranous colitis due to its disruption of the normal gut flora."},
      {"text": "*Candida albicans*", "explanation": "This is incorrect. *Candida* overgrowth would cause thrush or candidiasis, not pseudomembranous colitis."},
      {"text": "*Bacteroides fragilis*", "explanation": "This is incorrect. Clindamycin is often used to *treat* *B. fragilis* infections, although resistance is increasing."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0038.jpg"
  },
  {
    "id": 22,
    "category": "Clindamycin: Resistance (D-Test)",
    "questionText": "A lab tests an MRSA isolate and reports 'Erythromycin-Resistant, Clindamycin-Susceptible'. A D-test is performed (Panel A), showing a flattening of the clindamycin zone of inhibition. What is the mechanism and clinical implication?",
    "options": [
      {"text": "The organism has an efflux pump; clindamycin is safe to use.", "explanation": "This is incorrect. An efflux pump (like *mefA*) would not produce a positive D-test."},
      {"text": "The organism has an inducible *erm* gene; clindamycin should be reported as resistant.", "explanation": "This is correct. The 'D' shape indicates that erythromycin induced the *erm* gene, producing a methylase that makes the bacteria resistant to clindamycin. This means there is a high risk of therapeutic failure."},
      {"text": "The organism is constitutively resistant; clindamycin is resistant.", "explanation": "This is incorrect. Constitutive resistance would show no zone of inhibition at all around clindamycin (as in Panel D)."},
      {"text": "The organism is susceptible to both; clindamycin is safe to use.", "explanation": "This is incorrect. This is shown in Panel C, not Panel A."},
      {"text": "The organism is only resistant to erythromycin; clindamycin is safe to use.", "explanation": "This is incorrect. This is shown in Panel B, not Panel A."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0040.jpg"
  },
  {
    "id": 23,
    "category": "Clindamycin: Pharmacokinetics",
    "questionText": "Clindamycin is a preferred agent for treating a lung abscess. What key pharmacokinetic property, in addition to its anaerobic spectrum, makes it suitable for this indication?",
    "options": [
      {"text": "It is eliminated 100% unchanged in the urine.", "explanation": "This is incorrect. It is metabolized by the liver."},
      {"text": "It achieves high concentrations in the CSF.", "explanation": "This is incorrect. Clindamycin has *low* penetration into the CSF."},
      {"text": "It penetrates well into abscesses and is taken up by phagocytes.", "explanation": "This is correct. Clindamycin distributes well into tissues and is known to penetrate abscesses effectively, where anaerobes often reside. It is also taken up by phagocytic cells."},
      {"text": "It has 100% oral bioavailability.", "explanation": "This is incorrect. It has good (~90%) bioavailability, but this isn't the primary reason for its use in abscesses."},
      {"text": "It has an extremely long half-life of 70 hours.", "explanation": "This is incorrect. This describes azithromycin; clindamycin's half-life is ~3 hours."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0038.jpg"
  },
  {
    "id": 24,
    "category": "Clindamycin: Adverse Effects",
    "questionText": "A 28-year-old female is prescribed clindamycin vaginal cream for bacterial vaginosis. She reports using a latex diaphragm for contraception. What is the most important counseling point regarding this combination?",
    "options": [
      {"text": "The combination significantly increases the risk of *C. difficile* infection.", "explanation": "This is incorrect. The risk of *C. difficile* is not related to the diaphragm."},
      {"text": "The oleaginous base of the cream may weaken the latex diaphragm, leading to failure.", "explanation": "This is correct. The oily base in clindamycin vaginal cream (and suppositories) can weaken latex condoms and diaphragms, increasing the risk of contraceptive failure."},
      {"text": "The diaphragm will inactivate the clindamycin, leading to therapeutic failure.", "explanation": "This is incorrect. The clindamycin is not inactivated."},
      {"text": "The combination will cause a disulfiram-like reaction if she consumes alcohol.", "explanation": "This is incorrect. This is an adverse effect of cefotetan."},
      {"text": "This will cause irreversible staining of the diaphragm.", "explanation": "This is incorrect. The primary concern is structural failure, not staining."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0038.jpg"
  },
  {
    "id": 25,
    "category": "Clindamycin: Drug Interactions",
    "questionText": "A physician considers treating a patient with both clindamycin and erythromycin. Why is this combination antagonistic and should be avoided?",
    "options": [
      {"text": "They are both strong CYP3A4 inhibitors and will cause additive toxicity.", "explanation": "This is incorrect. This is a pharmacokinetic interaction, but the primary reason is pharmacodynamic antagonism at the target site. Also, clindamycin is not a CYP inhibitor."},
      {"text": "Erythromycin is an acid-labile base, and clindamycin is an acid.", "explanation": "This is incorrect. This is not the mechanism of their interaction."},
      {"text": "They bind to the same or nearby sites on the 50S ribosome and compete for binding.", "explanation": "This is correct. Both drugs (and chloramphenicol) bind to overlapping sites on the 23S rRNA of the 50S subunit. Their concurrent use can lead to competition for the target site, resulting in antagonism."},
      {"text": "Clindamycin induces the metabolism of erythromycin.", "explanation": "This is incorrect. Clindamycin is not a CYP inducer."},
      {"text": "Both drugs cause severe neuromuscular blockade.", "explanation": "This is incorrect. This is a toxicity of aminoglycosides."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0036.jpg"
  },
  {
    "id": 26,
    "category": "Chloramphenicol: Mechanism of Action",
    "questionText": "Chloramphenicol is a broad-spectrum, bacteriostatic antibiotic. What is its mechanism of action?",
    "options": [
      {"text": "It binds to the 30S subunit, blocking the A-site.", "explanation": "This is incorrect. This is the mechanism of tetracyclines."},
      {"text": "It binds to the 50S subunit and blocks the polypeptide exit tunnel.", "explanation": "This is incorrect. This is the mechanism of macrolides."},
      {"text": "It binds to the 50S subunit and inhibits peptidyl transferase by blocking tRNA binding at the A-site.", "explanation": "This is correct. Chloramphenicol binds to the 23S rRNA in the 50S subunit and interferes with the binding of tRNA to the A-site, which in turn prevents peptidyl transferase from forming the peptide bond."},
      {"text": "It binds to the 50S subunit, preventing the 70S initiation complex from forming.", "explanation": "This is incorrect. This is the mechanism of linezolid."},
      {"text": "It binds to the 30S subunit, causing misreading of the mRNA.", "explanation": "This is incorrect. This is the mechanism of aminoglycosides."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0041.jpg"
  },
  {
    "id": 27,
    "category": "Chloramphenicol: Adverse Effects (Pediatrics)",
    "questionText": "A premature neonate is given chloramphenicol for meningitis. The infant develops vomiting, abdominal distension, hypothermia, and an ashen-gray cyanosis, followed by cardiovascular collapse. This \"Gray Syndrome\" is caused by:",
    "options": [
      {"text": "A severe hypersensitivity reaction to the drug's nitrobenzene moiety.", "explanation": "This is incorrect. Gray syndrome is a dose-dependent toxicity, not an allergic reaction."},
      {"text": "The drug's inhibition of DNA gyrase in the neonate.", "explanation": "This is incorrect. This is not the drug's MOA or toxicity."},
      {"text": "Immaturity of both hepatic UGT and renal function, leading to toxic drug accumulation.", "explanation": "This is correct. Neonates cannot metabolize chloramphenicol (via UDP-glucuronyltransferase) or excrete it efficiently due to immature liver and kidney function, leading to toxic drug accumulation and this syndrome."},
      {"text": "The drug causing a disulfiram-like reaction with breast milk.", "explanation": "This is incorrect. This is not the mechanism."},
      {"text": "Irreversible binding to the neonate's mitochondrial ribosomes.", "explanation": "This is incorrect. While it *does* inhibit mitochondrial ribosomes, the *syndrome* is caused by acute, high-dose accumulation due to a lack of metabolism/clearance."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0043.jpg"
  },
  {
    "id": 28,
    "category": "Chloramphenicol: Adverse Effects",
    "questionText": "A 40-year-old patient who received chloramphenicol 2 months ago for a life-threatening infection presents with severe fatigue, pallor, petechiae, and a fever. A CBC reveals pancytopenia. This is most likely which rare, but fatal, adverse effect?",
    "options": [
      {"text": "Gray syndrome", "explanation": "This is incorrect. Gray syndrome is an acute toxicity seen in neonates."},
      {"text": "Dose-related, reversible myelosuppression", "explanation": "This is incorrect. That toxicity is dose-related, occurs *during* therapy, and is reversible."},
      {"text": "Idiosyncratic, irreversible aplastic anemia", "explanation": "This is correct. Chloramphenicol can cause a rare (idiopathic), irreversible aplastic anemia that presents weeks or months after therapy and is often fatal."},
      {"text": "Fanconi syndrome", "explanation": "This is incorrect. This is a renal toxicity from outdated tetracycline."},
      {"text": "Serotonin syndrome", "explanation": "This is incorrect. This is an interaction with linezolid."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0042.jpg"
  },
  {
    "id": 29,
    "category": "Chloramphenicol: Adverse Effects",
    "questionText": "A patient receiving high-dose IV chloramphenicol develops a *reversible* anemia, leukopenia, and thrombocytopenia. This dose-related bone marrow toxicity is a direct result of chloramphenicol inhibiting which of the following?",
    "options": [
      {"text": "Bacterial 30S ribosomes", "explanation": "This is incorrect. This is its antibacterial target, not its human toxicity target."},
      {"text": "Host mitochondrial protein synthesis", "explanation": "This is correct. Chloramphenicol is lipophilic and can enter mitochondria, which have 70S ribosomes. It inhibits mitochondrial protein synthesis (especially in red blood cells), leading to a dose-related, reversible bone marrow suppression."},
      {"text": "Bacterial acetyltransferase", "explanation": "This is incorrect. This is a bacterial *resistance* mechanism, not a human toxicity."},
      {"text": "Hepatic UDP-glucuronyltransferase", "explanation": "This is incorrect. This is the *metabolism* pathway; its absence in neonates *leads* to toxicity, but it's not the *mechanism* of the toxicity itself."},
      {"text": "Host DNA gyrase", "explanation": "This is incorrect. This is not the target."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0042.jpg"
  },
  {
    "id": 30,
    "category": "Chloramphenicol: Clinical Use",
    "questionText": "A 5-year-old child presents with a high fever, headache, and petechial rash. The family has a history of severe, life-threatening anaphylaxis to doxycycline. For a suspected diagnosis of Rocky Mountain Spotted Fever (RMSF), what is the *only* other effective antibiotic?",
    "options": [
      {"text": "Ceftriaxone", "explanation": "This is incorrect. Ceftriaxone is not effective against *Rickettsia*."},
      {"text": "Amoxicillin", "explanation": "This is incorrect. Penicillins are not effective against this atypical intracellular organism."},
      {"text": "Azithromycin", "explanation": "This is incorrect. Macrolides are not a first-line or reliable alternative for RMSF."},
      {"text": "Chloramphenicol", "explanation": "This is correct. Chloramphenicol is the only other effective agent for RMSF and was historically the alternative to tetracyclines in children and pregnant women, despite its own significant toxicities."},
      {"text": "Vancomycin", "explanation": "This is incorrect. Vancomycin is not effective against this atypical organism."}
    ],
    "correctAnswerIndex": 3,
    "slideImagePath": "images/L125_page-0042.jpg"
  },
  {
    "id": 31,
    "category": "Chloramphenicol: Pharmacokinetics",
    "questionText": "A patient is treated with IV chloramphenicol for bacterial meningitis. What pharmacokinetic property allows this drug to be effective for this indication?",
    "options": [
      {"text": "It is actively transported into the CSF by P-glycoprotein.", "explanation": "This is incorrect. P-glycoprotein is an efflux pump that would *remove* it from the CSF."},
      {"text": "It is highly lipophilic and achieves high concentrations in the CSF, even without inflammation.", "explanation": "This is correct. Chloramphenicol is highly lipophilic and is widely distributed, achieving good therapeutic concentrations in the CSF even when the meninges are not inflamed."},
      {"text": "It is 100% excreted unchanged in the urine, leading to high CSF levels.", "explanation": "This is incorrect. It is metabolized by the liver, and renal excretion is not related to CSF penetration."},
      {"text": "It is bacteriostatic and only slows bacterial growth.", "explanation": "This is incorrect. This is a pharmacodynamic property and a *limitation* for meningitis, not the reason for its efficacy."},
      {"text": "It is a prodrug activated only in the CSF by esterases.", "explanation": "This is incorrect. It is a prodrug (succinate salt) activated in the *plasma* by esterases."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0042.jpg"
  },
  {
    "id": 32,
    "category": "Chloramphenicol: Resistance",
    "questionText": "A gram-negative bacterium is found to be resistant to chloramphenicol. What is the primary, plasmid-mediated mechanism of acquired resistance?",
    "options": [
      {"text": "Production of a methylase that alters the 23S rRNA.", "explanation": "This is incorrect. This is the $MLS_B$ resistance mechanism for macrolides/clindamycin."},
      {"text": "Inactivation by a bacterial acetyltransferase.", "explanation": "This is correct. The primary mechanism of acquired resistance to chloramphenicol is the production of a plasmid-encoded acetyltransferase that acetylates the drug, preventing it from binding to the ribosome."},
      {"text": "Modification of the target to D-Ala-D-Lactate.", "explanation": "This is incorrect. This is the resistance mechanism for vancomycin in VRE."},
      {"text": "An efflux pump encoded by the *tet(AE)* gene.", "explanation": "This is incorrect. This is a tetracycline resistance mechanism."},
      {"text": "Mutation of the 16S rRNA binding site.", "explanation": "This is incorrect. Chloramphenicol binds to the 50S subunit."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0042.jpg"
  },
  {
    "id": 33,
    "category": "Linezolid: Mechanism of Action",
    "questionText": "Linezolid is a bacteriostatic antibiotic used for resistant gram-positive infections. What is its unique mechanism of action?",
    "options": [
      {"text": "It binds to the 30S subunit, blocking the A-site.", "explanation": "This is incorrect. This is the mechanism of tetracyclines."},
      {"text": "It binds to the 50S subunit and blocks the polypeptide exit tunnel.", "explanation": "This is incorrect. This is the mechanism of macrolides."},
      {"text": "It binds to the 23S rRNA of the 50S subunit, preventing formation of the 70S initiation complex.", "explanation": "This is correct. Linezolid binds to a unique site on the 23S rRNA, preventing the 70S initiation complex from forming, thus inhibiting protein synthesis before it can even begin."},
      {"text": "It binds to the 50S subunit and inhibits peptidyl transferase.", "explanation": "This is incorrect. This is the mechanism of chloramphenicol."},
      {"text": "It binds to the 30S subunit and causes misreading of the mRNA.", "explanation": "This is incorrect. This is the mechanism of aminoglycosides."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0044.jpg"
  },
  {
    "id": 34,
    "category": "Linezolid: Spectrum of Activity",
    "questionText": "A patient has a mixed infection with VRE (*Enterococcus faecium*) and *Pseudomonas aeruginosa*. Linezolid is started. While it will cover the VRE, it is intrinsically resistant against *P. aeruginosa* because its spectrum is limited to:",
    "options": [
      {"text": "Anaerobic bacteria only.", "explanation": "This is incorrect. Linezolid is *resistant* against most anaerobic bacteria and covers aerobic gram-positives."},
      {"text": "Gram-positive bacteria only.", "explanation": "This is correct. Linezolid's spectrum of activity is limited to gram-positive bacteria (Strep, Staph, Enterococcus), including resistant strains like MRSA and VRE. It is intrinsically resistant to aerobic gram-negative bacteria."},
      {"text": "Gram-negative bacteria only.", "explanation": "This is incorrect. Its spectrum is gram-positive only."},
      {"text": "Atypical bacteria only.", "explanation": "This is incorrect. This is not its primary spectrum."},
      {"text": "All bacteria except *E. coli*.", "explanation": "This is incorrect. It is resistant against all gram-negative bacteria."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0045.jpg"
  },
  {
    "id": 35,
    "category": "Linezolid: Adverse Effects (Interactions)",
    "questionText": "A 50-year-old man on fluoxetine (an SSRI) for depression is hospitalized with MRSA pneumonia and started on linezolid. He develops confusion, agitation, hyperreflexia, and hyperthermia. This \"serotonin syndrome\" is a result of linezolid's inhibition of which enzyme?",
    "options": [
      {"text": "CYP3A4", "explanation": "This is incorrect. CYP3A4 inhibition is a property of erythromycin and clarithromycin."},
      {"text": "Monoamine Oxidase (MAO)", "explanation": "This is correct. Linezolid is a weak, non-specific monoamine oxidase (MAO) inhibitor. This action increases serotonin levels, and when combined with other serotonergic drugs like SSRIs, it can precipitate serotonin syndrome."},
      {"text": "UDP-glucuronyltransferase (UGT)", "explanation": "This is incorrect. This is the metabolic pathway for chloramphenicol."},
      {"text": "Bacterial acetyltransferase", "explanation": "This is incorrect. This is a bacterial resistance enzyme for chloramphenicol."},
      {"text": "P-glycoprotein", "explanation": "This is incorrect. This is an efflux pump inhibited by macrolides."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0046.jpg"
  },
  {
    "id": 36,
    "category": "Linezolid: Adverse Effects (Interactions)",
    "questionText": "A patient on linezolid attends a party and consumes aged cheeses and red wine. They subsequently develop a hypertensive crisis. This reaction is due to linezolid's MAO-inhibiting properties, which prevent the breakdown of what substance found in these foods?",
    "options": [
      {"text": "Alcohol", "explanation": "This is incorrect. A disulfiram-like reaction with alcohol is seen with cefotetan, not linezolid."},
      {"text": "Calcium", "explanation": "This is incorrect. This interaction is characteristic of tetracyclines."},
      {"text": "Tyramine", "explanation": "This is correct. Tyramine is a substance found in aged foods (cheeses, wines, cured meats). It is normally broken down by MAO in the gut. When MAO is inhibited by linezolid, tyramine is absorbed, displaces norepinephrine, and can cause a hypertensive crisis."},
      {"text": "Tryptophan", "explanation": "This is incorrect. Tryptophan is a precursor to serotonin, but tyramine is the specific food substance responsible for this hypertensive reaction."},
      {"text": "Folic acid", "explanation": "This is incorrect. This is not related."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0046.jpg"
  },
  {
    "id": 37,
    "category": "Linezolid: Adverse Effects",
    "questionText": "A 55-year-old male has been on linezolid for 6 weeks for a complex MRSA osteomyelitis. He reports new-onset blurred vision and a \"stocking-glove\" pattern of numbness in his feet. These long-term toxicities are believed to be related to:",
    "options": [
      {"text": "Neuromuscular blockade", "explanation": "This is incorrect. This is an acute toxicity of aminoglycosides."},
      {"text": "Mitochondrial toxicity", "explanation": "This is correct. Long-term therapy (≥28 days) with linezolid is associated with mitochondrial toxicities, which can manifest as peripheral neuropathy, optic neuritis (vision loss), and lactic acidosis."},
      {"text": "Deposition in bone and teeth", "explanation": "This is incorrect. This is a toxicity of tetracyclines in children."},
      {"text": "Inhibition of CYP2C9", "explanation": "This is incorrect. This is an interaction of chloramphenicol."},
      {"text": "Gray syndrome", "explanation": "This is incorrect. This is an acute toxicity of chloramphenicol in neonates."}
    ],
    "correctAnswerIndex": 1,
    "slideImagePath": "images/L125_page-0045.jpg"
  },
  {
    "id": 38,
    "category": "Linezolid: Adverse Effects",
    "questionText": "A patient receiving linezolid for a VRE infection has routine bloodwork drawn. Which of the following is the *most common* reversible hematologic toxicity, typically seen after 2 weeks of therapy?",
    "options": [
      {"text": "Aplastic anemia", "explanation": "This is incorrect. This is a rare, irreversible toxicity of chloramphenicol."},
      {"text": "Hemolytic anemia", "explanation": "This is incorrect. This is not the most common hematologic toxicity."},
      {"text": "Thrombocytopenia", "explanation": "This is correct. The main hematologic toxicity of linezolid is a reversible, duration-dependent (usually >2 weeks) thrombocytopenia."},
      {"text": "Eosinophilia", "explanation": "This is incorrect. Eosinophilic pneumonia is a rare toxicity of daptomycin."},
      {"text": "Leukocytosis", "explanation": "This is incorrect. The toxicity is bone marrow *suppression*, which would cause leukopenia, not leukocytosis."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0045.jpg"
  },
  {
    "id": 39,
    "category": "Linezolid: Pharmacokinetics",
    "questionText": "A 60-year-old patient with MRSA bacteremia is being treated with IV linezolid. The patient is stable and ready for discharge. The team switches him to PO linezolid at the exact same dose. This simple IV-to-PO switch is possible due to which pharmacokinetic property?",
    "options": [
      {"text": "It has an extremely long half-life of 70 hours.", "explanation": "This is incorrect. This describes azithromycin; linezolid's half-life is ~5 hours."},
      {"text": "It is not metabolized and is cleared by the liver.", "explanation": "This is incorrect. It has minimal metabolism, but its 100% bioavailability is the key property for IV-to-PO switching."},
      {"text": "It has 100% oral bioavailability.", "explanation": "This is correct. Linezolid has 100% oral bioavailability, meaning the entire oral dose is absorbed, so the oral dose is the same as the IV dose."},
      {"text": "It is a weak MAO inhibitor.", "explanation": "This is incorrect. This is a pharmacodynamic property related to its adverse effects, not its bioavailability."},
      {"text": "It is excreted as an active drug in the feces.", "explanation": "This is incorrect. This describes doxycycline."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0045.jpg"
  },
  {
    "id": 40,
    "category": "Linezolid: Spectrum of Activity",
    "questionText": "Linezolid is generally considered a bacteriostatic agent, similar to other protein synthesis inhibitors. However, it is known to be *bactericidal* against which of the following organisms?",
    "options": [
      {"text": "*Staphylococci* (including MRSA)", "explanation": "This is incorrect. Linezolid is bacteriostatic against *Staphylococci*."},
      {"text": "*Enterococci* (including VRE)", "explanation": "This is incorrect. Linezolid is bacteriostatic against *Enterococci*."},
      {"text": "*Streptococci* (including *S. pneumoniae*)", "explanation": "This is correct. Linezolid is unique in that it is bacteriostatic against *Staph* and *Enterococcus*, but it is *bactericidal* against most strains of *Streptococci*."},
      {"text": "*Listeria monocytogenes*", "explanation": "This is incorrect. It is active against *Listeria*, but bacteriostatic."},
      {"text": "*Mycobacterium tuberculosis*", "explanation": "This is incorrect. It is active against TB, but bacteriostatic."}
    ],
    "correctAnswerIndex": 2,
    "slideImagePath": "images/L125_page-0045.jpg"
  }
];